CD40LG and B-cell chronic lymphocytic leukemia: In addition to contributing to CLL cell survival, CD40L has been implicated in drug resistance in CLL, with microenvironmental agonists including CD40L inducing NF-κB mediated resistance to Venetoclax and ibrutinib (88, 112, 113).